Just released...
http://www.bloomberg.com/news/2011-09-12/roche-seeks-fda-approval-for-skin-cancer-drug-frings-says.html
I'm wondering whether there is a tie in with our 'Internal Discovery Program' ie: Sonic Hedgehog Pathway for basal cell carcinoma.
Here is reference to that in our latest report on page 9
http://www.aspecthuntley.com.au/asxdata/20101028/pdf/01113972.pdf
Regards,
TI
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.005(0.37%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.40 | $1.36 | $211.9K | 152.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4103 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 2028 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |